Patient Integration is increasingly urgent in oncology research, as growing complexity fuels demand for patient-level translation and outcomes that reflect real needs across preclinical and clinical ...
Mobile app engagement in an eight week mHealth program was tied to meaningful pain improvement in adults with chronic pain ...
A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite the cardiovascular risk.
New national hepatitis elimination profiles reveal policy and implementation gaps in reaching global viral hepatitis elimination targets.
Telemedicine in bronchial asthma was linked to better asthma control, especially with telemonitoring, education, or combined ...
New NHANES data link increased time outdoors with higher testosterone and reduced risk of low testosterone in men. Find out ...
THE gut microbiome was shown to predict how well patients with Type 2 diabetes responded to newer glucose-lowering therapies ...
The Office of Inspector General's bulletin provides a framework for pharma companies selling prescription ...
EEG-based machine learning predicted SSRI treatment response in depression with high accuracy. Learn how brain signals could ...
As pharma raced to meet climate targets in 2024 to 2025, it proved that scaling medicines no longer has to mean scaling emissions.
Study data show stronger Ph+ acute lymphoblastic leukaemia immune activation with dasatinib plus blinatumomab than with ponatinib combinations, highlighting sustained natural killer cell responses.
Real-world EHR data suggest ACE inhibitor use is independently associated with lower all-cause mortality in idiopathic pulmonary fibrosis, while no similar survival association was observed in COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results